Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Radiaction Medical Ltd. Receives FDA Clearance for its Innovative Radiation Protection System and Secures $10M for US Launch and Commercialization
Radiaction Medical Ltd. (“Radiaction”), an innovative medical device company focused on radiation protection in the interventional […]
Myeloid Therapeutics and Prime Medicine Enter Into Exclusive Option and Research Collaboration to Develop and Accelerate Next-Generation RNA-based Gene-Editing Technology, RetroT™
Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and […]
Oxford Science Enterprises Strengthens Investment Teams with Two New Appointments
Oxford Science Enterprises, the Science Business Builder and preferred investment partner of the University of […]
Neuron23 Closes $100 Million Series C Financing Round, Nominates Clinical Candidate for Parkinson's Disease
Neuron23™ Inc., an early stage biotechnology company focused on developing precision medicines for genetically defined […]
Ian Fraser Appointed as EVP Clinical Development
Bionical Emas, a global Contract Research Organisation (CRO) providing services to the pharmaceutical and biotech […]
XNK Therapeutics Raises SEK 132 Million to Accelerate Growth
XNK Therapeutics AB (“XNK”) today announced it has secured a private placement of SEK 132 million, […]
DECISIO Reveals New Leadership and Closes Series B Funding Round
DECISIO has appointed Major General Elder Granger, M.D. (retired) to the company’s Board of Directors. Dr. Granger is currently […]
Immunovia Appoints Jeff Borcherding, Previously Chief Marketing Officer at Myriad Genetics, to Lead Immunovia's US Business
Immunovia (Nasdaq Stockholm: IMMNOV) has appointed Jeff Borcherding as CEO of its US subsidiary Immunovia, Inc. He […]
Leading Femtech Brand INNOVO Appoints New CFO
Today Atlantic Therapeutics, a Galway-based MedTech and Femtech innovator, is pleased to announce the appointment […]
MindMed Announces Transition of CFO
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more